Literature DB >> 21945903

CCR3 Blockade Attenuates Eosinophilic Ileitis and Associated Remodeling.

Joanne C Masterson1, Eóin N McNamee, Paul Jedlicka, Sophie Fillon, Joseph Ruybal, Lindsay Hosford, Jesús Rivera-Nieves, James J Lee, Glenn T Furuta.   

Abstract

Intestinal remodeling and stricture formation is a complication of inflammatory bowel disease (IBD) that often requires surgical intervention. Although eosinophils are associated with mucosal remodeling in other organs and are increased in IBD tissues, their role in IBD-associated remodeling is unclear. Histological and molecular features of ileitis and remodeling were assessed using immunohistochemical, histomorphometric, flow cytometric, and molecular analysis (real-time RT-PCR) techniques in a murine model of chronic eosinophilic ileitis. Collagen protein was assessed by Sircol assay. Using a spontaneous eosinophilic Crohn's-like mouse model SAMP1/SkuSlc, we demonstrate an association between ileitis progression and remodeling over the course of 40 weeks. Mucosal and submucosal eosinophilia increased over the time course and correlated with increased histological inflammatory indices. Ileitis and remodeling increased over the 40 weeks, as did expression of fibronectin. CCR3-specific antibody-mediated reduction of eosinophils resulted in significant decrease in goblet cell hyperplasia, muscularis propria hypertrophy, villus blunting, and expression of inflammatory and remodeling genes, including fibronectin. Cellularity of local mesenteric lymph nodes, including T- and B-lymphocytes, was also significantly reduced. Thus, eosinophils participate in intestinal remodeling, supporting eosinophils as a novel therapeutic target.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945903      PMCID: PMC3204091          DOI: 10.1016/j.ajpath.2011.07.039

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

1.  Inhibition of airway remodeling in IL-5-deficient mice.

Authors:  Jae Youn Cho; Marina Miller; Kwang Je Baek; Ji Won Han; Jyothi Nayar; Sook Young Lee; Kirsti McElwain; Shauna McElwain; Stephanie Friedman; David H Broide
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

2.  Esophageal remodeling in pediatric eosinophilic esophagitis.

Authors:  Seema S Aceves; Robert O Newbury; Ranjan Dohil; John F Bastian; David H Broide
Journal:  J Allergy Clin Immunol       Date:  2007-01       Impact factor: 10.793

3.  Ablation of eosinophils leads to a reduction of allergen-induced pulmonary pathology.

Authors:  J Paul Justice; Michael T Borchers; Jeffrey R Crosby; Edith M Hines; Huahao H Shen; Sergei I Ochkur; Michael P McGarry; Nancy A Lee; James J Lee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-09-13       Impact factor: 5.464

4.  Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody.

Authors:  D I Blyth; T F Wharton; M S Pedrick; T J Savage; S Sanjar
Journal:  Am J Respir Cell Mol Biol       Date:  2000-08       Impact factor: 6.914

5.  Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase.

Authors:  Elizabeth Forbes; Tosei Murase; Ming Yang; Klaus I Matthaei; James J Lee; Nancy A Lee; Paul S Foster; Simon P Hogan
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

6.  Eosinophils express functional IL-13 in eosinophilic inflammatory diseases.

Authors:  Peter Schmid-Grendelmeier; Frank Altznauer; Barbra Fischer; Christian Bizer; Alex Straumann; Günter Menz; Kurt Blaser; Brunello Wüthrich; Hans-Uwe Simon
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

7.  Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics.

Authors:  Patrick Flood-Page; Andrew Menzies-Gow; Simon Phipps; Sun Ying; Arun Wangoo; Mara S Ludwig; Neil Barnes; Douglas Robinson; A Barry Kay
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

8.  Interleukin-5 participates in the pathogenesis of ileitis in SAMP1/Yit mice.

Authors:  Hidetoshi Takedatsu; Keiichi Mitsuyama; Satoshi Matsumoto; Kazuyo Handa; Asuka Suzuki; Hiroko Takedatsu; Hideyuki Funabashi; Yoshio Okabe; Taeko Hara; Atsushi Toyonaga; Michio Sata
Journal:  Eur J Immunol       Date:  2004-06       Impact factor: 5.532

9.  Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia.

Authors:  G T Furuta; J R Turner; C T Taylor; R M Hershberg; K Comerford; S Narravula; D K Podolsky; S P Colgan
Journal:  J Exp Med       Date:  2001-05-07       Impact factor: 14.307

10.  Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo.

Authors:  Channing Yu; Alan B Cantor; Haidi Yang; Carol Browne; Richard A Wells; Yuko Fujiwara; Stuart H Orkin
Journal:  J Exp Med       Date:  2002-06-03       Impact factor: 14.307

View more
  21 in total

1.  Eosinophilic esophagitis: epithelial mesenchymal transition contributes to esophageal remodeling and reverses with treatment.

Authors:  Amir F Kagalwalla; Noorain Akhtar; Samantha A Woodruff; Bryan A Rea; Joanne C Masterson; Vincent Mukkada; Kalyan R Parashette; Jian Du; Sophie Fillon; Cheryl A Protheroe; James J Lee; Katie Amsden; Hector Melin-Aldana; Kelley E Capocelli; Glenn T Furuta; Steven J Ackerman
Journal:  J Allergy Clin Immunol       Date:  2012-04-01       Impact factor: 10.793

2.  IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis.

Authors:  Carlo De Salvo; Xiao-Ming Wang; Luca Pastorelli; Benedetta Mattioli; Sara Omenetti; Kristine A Buela; Saleem Chowdhry; Rekha R Garg; Wendy A Goodman; Alex Rodriguez-Palacios; Dirk E Smith; Derek W Abbott; Fabio Cominelli; Giorgos Bamias; Wei Xin; James J Lee; Maurizio Vecchi; Theresa T Pizarro
Journal:  Am J Pathol       Date:  2016-02-22       Impact factor: 4.307

Review 3.  The expanding role(s) of eosinophils in health and disease.

Authors:  Elizabeth A Jacobsen; Richard A Helmers; James J Lee; Nancy A Lee
Journal:  Blood       Date:  2012-08-30       Impact factor: 22.113

4.  Eosinophil-dependent skin innervation and itching following contact toxicant exposure in mice.

Authors:  James J Lee; Cheryl A Protheroe; Huijun Luo; Sergei I Ochkur; Gregory D Scott; Katie R Zellner; Randall J Raish; Mark V Dahl; Miriam L Vega; Olivia Conley; Rachel M Condjella; Jake A Kloeber; Joseph L Neely; Yash S Patel; Patty Maizer; Andrew Mazzolini; Allison D Fryer; Noah W Jacoby; David B Jacoby; Nancy A Lee
Journal:  J Allergy Clin Immunol       Date:  2014-08-13       Impact factor: 10.793

5.  Local hypersensitivity reaction in transgenic mice with squamous epithelial IL-5 overexpression provides a novel model of eosinophilic oesophagitis.

Authors:  Joanne C Masterson; Eóin N McNamee; Lindsay Hosford; Kelley E Capocelli; Joseph Ruybal; Sophie A Fillon; Alfred D Doyle; Holger K Eltzschig; Anil K Rustgi; Cheryl A Protheroe; Nancy A Lee; James J Lee; Glenn T Furuta
Journal:  Gut       Date:  2012-11-17       Impact factor: 23.059

Review 6.  Roles and regulation of gastrointestinal eosinophils in immunity and disease.

Authors:  YunJae Jung; Marc E Rothenberg
Journal:  J Immunol       Date:  2014-08-01       Impact factor: 5.422

7.  Eosinophils and IL-33 Perpetuate Chronic Inflammation and Fibrosis in a Pediatric Population with Stricturing Crohn's Ileitis.

Authors:  Joanne C Masterson; Kelley E Capocelli; Lindsay Hosford; Kathryn Biette; Eóin N McNamee; Edwin F de Zoeten; Rachel Harris; Shahan D Fernando; Paul Jedlicka; Cheryl Protheroe; James J Lee; Glenn T Furuta
Journal:  Inflamm Bowel Dis       Date:  2015-10       Impact factor: 5.325

8.  Regulation of eotaxin-3/CC chemokine ligand 26 expression by T helper type 2 cytokines in human colonic myofibroblasts.

Authors:  K Takahashi; H Imaeda; T Fujimoto; H Ban; S Bamba; T Tsujikawa; M Sasaki; Y Fujiyama; A Andoh
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

9.  Novel peptide nanoparticle-biased antagonist of CCR3 blocks eosinophil recruitment and airway hyperresponsiveness.

Authors:  Milica Grozdanovic; Kimberly G Laffey; Hazem Abdelkarim; Ben Hitchinson; Anantha Harijith; Hyung-Geon Moon; Gye Young Park; Lee K Rousslang; Joanne C Masterson; Glenn T Furuta; Nadya I Tarasova; Vadim Gaponenko; Steven J Ackerman
Journal:  J Allergy Clin Immunol       Date:  2018-05-17       Impact factor: 10.793

10.  Eosinophil activities modulate the immune/inflammatory character of allergic respiratory responses in mice.

Authors:  E A Jacobsen; W E Lesuer; L Willetts; K R Zellner; K Mazzolini; N Antonios; B Beck; C Protheroe; S I Ochkur; D Colbert; P Lacy; R Moqbel; J Appleton; N A Lee; J J Lee
Journal:  Allergy       Date:  2013-11-25       Impact factor: 13.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.